9-Cis retinoic acid reduces 1alpha,25-dihydroxycholecalciferol-induced renal calcification by altering vitamin K-dependent gamma-carboxylation of matrix gamma-carboxyglutamic acid protein in A/J male mice

J Nutr. 2008 Dec;138(12):2337-41. doi: 10.3945/jn.108.093724.

Abstract

Matrix gamma-carboxyglutamic acid protein (MGP), a vitamin K-dependent protein, is involved in regulation of tissue calcification. We previously reported that 9-cis retinoic acid (RA) mitigates 1alpha,25-dihydroxycholecalciferol [1,25(OH)(2)D3]-induced renal calcification in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung cancer A/J male mouse model. This raised the question if the mechanism(s) underlying this calcification involves vitamin K. We assessed expression and vitamin K dependent gamma-carboxylation of MGP and vitamin K concentrations [phylloquinone (PK), as well as its conversion product, menaquinone-4 (MK-4)] in tissues obtained from NNK-injected A/J male mice fed 1,25(OH)(2)D3 (2.5 microg/kg diet; D group) +/- RA (15 mg/kg diet) for 20 wk. Renal calcification was only observed in the D group (2/10; 20% of the group). Renal MGP mRNA and uncarboxylated MGP (ucMGP) increased in response to D (P < 0.05) but not in response to RA or RA + D. In contrast, gamma-carboxylated MGP increased to 2.2-fold of the control in response to D+RA (P < 0.05) but not in response to RA or D alone. Although all diets contained equal amounts of PK, the kidney MK-4 concentration was higher in the D group (P < 0.05) and lower in the RA group (P < 0.05) compared with the RA+D or control groups. Renal PK concentrations were lower in the RA and RA+D groups than in the control and D groups (P < 0.05). These data suggest that 9-cis RA mitigated 1,25(OH)(2)D3-induced renal calcification by modifying the 1,25(OH)(2)D3-induced increase in ucMGP. The mechanisms by which 9-cis RA and 1,25(OH)(2)D3 alter vitamin K concentrations warrant further investigation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alitretinoin
  • Animals
  • Base Sequence
  • Calcinosis / etiology
  • Calcinosis / metabolism
  • Calcinosis / prevention & control*
  • Calcitriol / administration & dosage
  • Calcitriol / antagonists & inhibitors
  • Calcitriol / metabolism
  • Calcitriol / toxicity*
  • Calcium-Binding Proteins / genetics
  • Calcium-Binding Proteins / metabolism*
  • Carbon-Carbon Ligases / metabolism*
  • Carcinogens / administration & dosage
  • Carcinogens / antagonists & inhibitors
  • Carcinogens / toxicity
  • DNA Primers / genetics
  • Dietary Supplements
  • Extracellular Matrix Proteins / genetics
  • Extracellular Matrix Proteins / metabolism*
  • Kidney Diseases / etiology
  • Kidney Diseases / metabolism
  • Kidney Diseases / prevention & control*
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Matrix Gla Protein
  • Mice
  • Mice, Inbred A
  • Nitrosamines / toxicity
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Tretinoin / administration & dosage
  • Tretinoin / pharmacology*
  • Vitamin K / metabolism

Substances

  • Calcium-Binding Proteins
  • Carcinogens
  • DNA Primers
  • Extracellular Matrix Proteins
  • Nitrosamines
  • RNA, Messenger
  • Vitamin K
  • Alitretinoin
  • Tretinoin
  • 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
  • Carbon-Carbon Ligases
  • glutamyl carboxylase
  • Calcitriol